Physician profile
Michael S Levy
NPI 1104814821
$556.53
in general payments reported to CMS, 2019-2025
14 companies · $18.25 in 2025
The $18.25 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $16.19 · 2022: $29.63 · 2023: $137 · 2024: $116 · 2025: $18.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $269.29 | 2019-2025 | Trident, Triathlon, Restoration |
| Azurity Pharmaceuticals, INC. | $69.53 | 2023 | Horizant |
| Sanara Medtech INC. | $40.80 | 2022-2024 | Celleraterx |
| Kyowa Kirin, INC. | $21.02 | 2023 | Nourianz |
| Biogen, INC. | $18.87 | 2023 | Spinraza |
| Vanda Pharmaceuticals INC. | $18.00 | 2024 | Ponvory |
| Life Molecular Imaging Ltd | $17.94 | 2024 | Neuraceq |
| Alnylam Pharmaceuticals INC. | $16.69 | 2024 | Amvuttra |
| Liberty Surgical INC. | $16.22 | 2019 | |
| Depuy Synthes Sales INC. | $16.19 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.34 | 2023 | Seglentis |
| Teva Pharmaceuticals USA, INC. | $12.94 | 2023 | Austedo Xr |
| Ferring Pharmaceuticals INC. | $12.38 | 2022 | |
| Medtronic USA, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.